2021
DOI: 10.1007/s00436-021-07364-9
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of immunoprotective effects of recombinant proteins and DNA vaccines derived from Eimeria tenella surface antigen 6 and 15 in vivo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(6 citation statements)
references
References 24 publications
0
6
0
Order By: Relevance
“…The expression of SAG is differentially regulated between oocyst/zygotes and second-generation cleavage stages, with only one being specifically expressed in the zygotes, a few in both stages, and most in the second generation cleavage ( Tabares et al, 2004 ), with the SAG B gene being specifically expressed in the second-generation cleavage peak expression in the second generation of cleistogamy. In recent years, many researchers have investigated the immunogenicity of SAG proteins, such as SAG1 ( Vo et al, 2021 ), SAG2, SAG4 ( Zhao et al, 2020b ), SAG6, SAG15 ( Geng et al, 2022 ), SAG16, SAG22, SAG23 ( Song et al, 2021 ; Zhao et al, 2021 ), among which SAG1, SAG4, SAG15, and SAG22 have candidate antigenic genes to be anticoccidial vaccines. In general, protective antigens will prefer proteins expressed in the intracellular phase or in the metabolically active phase of the worm, whereas SAG22 belongs to the SAG B gene, which is capable of efficient expression in the second generation of cleavers.…”
Section: Discussionmentioning
confidence: 99%
“…The expression of SAG is differentially regulated between oocyst/zygotes and second-generation cleavage stages, with only one being specifically expressed in the zygotes, a few in both stages, and most in the second generation cleavage ( Tabares et al, 2004 ), with the SAG B gene being specifically expressed in the second-generation cleavage peak expression in the second generation of cleistogamy. In recent years, many researchers have investigated the immunogenicity of SAG proteins, such as SAG1 ( Vo et al, 2021 ), SAG2, SAG4 ( Zhao et al, 2020b ), SAG6, SAG15 ( Geng et al, 2022 ), SAG16, SAG22, SAG23 ( Song et al, 2021 ; Zhao et al, 2021 ), among which SAG1, SAG4, SAG15, and SAG22 have candidate antigenic genes to be anticoccidial vaccines. In general, protective antigens will prefer proteins expressed in the intracellular phase or in the metabolically active phase of the worm, whereas SAG22 belongs to the SAG B gene, which is capable of efficient expression in the second generation of cleavers.…”
Section: Discussionmentioning
confidence: 99%
“…Detailed studies in Eimeria genomics with novel tools have revealed many microbial proteins that are considered as the candidates of vaccine antigens ( 47 , 48 ). Many Eimeria antigens are utilized to construct the anticoccidial vaccines, such as surface antigen ( 49 ), apical membrane antigen ( 11 , 50 ), microneme ( 51 , 52 ), rhoptry, profilin ( 53 ) etc. Although the antigens mentioned above have been proved to be effective in eliciting host immunity against the Eimeria species, these antigens could not provide fully immunoprotections against coccidiosis.…”
Section: Discussionmentioning
confidence: 99%
“…Vaccines are promising alternatives to anticoccidial drugs for disease control, but live vaccines require to replicate parasites to induce the host immune system, which takes a considerable amount of time and results in a high risk of triggering subclinical coccidiosis 6 . DNA vaccines, as the next‐generation vaccines, have been frequently developed against Eimeria infection, but no commercially available vaccines have reached the market 7–9 . To develop effective methods for the control of chicken coccidiosis, it is necessary to deeply comprehend the possible mechanism of the immune response.…”
Section: Introductionmentioning
confidence: 99%
“…6 DNA vaccines, as the next-generation vaccines, have been frequently developed against Eimeria infection, but no commercially available vaccines have reached the market. [7][8][9] To develop effective methods for the control of chicken coccidiosis, it is necessary to deeply comprehend the possible mechanism of the immune response.Song Wang, Danni Wang and Yilin Bai contributed to the work equally and should be regarded as co-first authors.…”
mentioning
confidence: 99%